跳至主要内容
临床试验/NCT03823859
NCT03823859已完成不适用

Metabolomics of Thyroid Hormones

University Hospital, Basel, Switzerland1 个研究点 分布在 1 个国家目标入组 332 人开始时间: 2018年12月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
332
试验地点
1
主要终点
Metabolome signature of thyroid Hormone Status (MSTH)

研究概览

简要总结

The aim of this study is to develop a metabolome signature of thyroid hormone status. The metabolome signature could be useful in diagnosis and treatment of thyroid dysfunction diseases, especially in cases where TSH cannot be reliably used.

详细描述

Primary Hypothyroidism is a frequent endocrine disorder, where the thyroid gland does not produce sufficient amounts of thyroid hormones. The substitution therapy is guided by measurement of the pituitary gland hormone thyrotropin (TSH). Patients with central hypothyroidism in whom pituitary insufficiency leads to hypothyroidism, TSH cannot be used to guide therapy. So far there are no reliable methods for therapy control in patients with central hypothyroidism.

The measurement of small endogenous metabolites might give investigators a metabolomics profile. This could help to discriminate between euthyroid, hypothyroid and hyperthyroid state and therefore could be used for diagnosis and therapy control of thyroid dysfunction diseases.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All participants:
  • Age 18 to 80 years
  • BMI 19 to 35 kg/m2
  • Informed consent as documented by signature
  • A) Patients with primary hyperthyroidism TSH < 0.2 mIU/l and free thyroxine (fT4) > 25 pM or fT3 > 8 pM
  • B) Patients with primary hypothyroidism, currently not sufficiently substituted TSH > 8 milli-International unit (mIU)/l or fT4 < 10 pM
  • C) Patients with diagnosis of primary hypothyroidism, sufficiently substituted Documented diagnosis of primary hypothyroidism Substitution with L-Thyroxin TSH in target range between 0.5 and 2.5 mIU/l
  • D) Patients with secondary hypothyroidism Pituitary disease with documented secondary hypothyroidism

排除标准

  • Diabetes mellitus (HbA1c >6.5%)
  • Severe concomitant diseases: chronic heart failure, liver cirrhosis, kidney failure, active cancer
  • Abuse of alcohol or illicit drugs
  • Women who are pregnant or breast feeding
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant
  • Previous enrolment into the current study

结局指标

主要结局

Metabolome signature of thyroid Hormone Status (MSTH)

时间窗: baseline/single visit

The MSTH will be tested against the current standard of diagnosis which is serum TSH level by multiple linear regression.

次要结局

  • Resting energy expenditure (REE)(baseline/single visit)
  • Body composition concerning fat mass(baseline/single visit)
  • Body composition concerning muscle mass(baseline/single visit)

研究者

发起方
University Hospital, Basel, Switzerland
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验